196 related articles for article (PubMed ID: 27007686)
1. Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Mar; 10(2):026002. PubMed ID: 27007686
[TBL] [Abstract][Full Text] [Related]
2. Human sweat metabolomics for lung cancer screening.
Calderón-Santiago M; Priego-Capote F; Turck N; Robin X; Jurado-Gámez B; Sanchez JC; Luque de Castro MD
Anal Bioanal Chem; 2015 Jul; 407(18):5381-92. PubMed ID: 25935675
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics analysis of exhaled breath condensate for discrimination between lung cancer patients and risk factor individuals.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Breath Res; 2016 Feb; 10(1):016011. PubMed ID: 26866403
[TBL] [Abstract][Full Text] [Related]
4. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.
López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath condensate biomarkers for lung cancer.
Campanella A; De Summa S; Tommasi S
J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
[TBL] [Abstract][Full Text] [Related]
6. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
7. Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study.
Corradi M; Poli D; Banda I; Bonini S; Mozzoni P; Pinelli S; Alinovi R; Andreoli R; Ampollini L; Casalini A; Carbognani P; Goldoni M; Mutti A
J Breath Res; 2015 Jan; 9(2):027101. PubMed ID: 25634546
[TBL] [Abstract][Full Text] [Related]
8. Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode.
Peralbo-Molina A; Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
Anal Chim Acta; 2015 Aug; 887():118-126. PubMed ID: 26320793
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome.
Bos LD; Weda H; Wang Y; Knobel HH; Nijsen TM; Vink TJ; Zwinderman AH; Sterk PJ; Schultz MJ
Eur Respir J; 2014 Jul; 44(1):188-97. PubMed ID: 24743964
[TBL] [Abstract][Full Text] [Related]
10. Epidermal Growth Factor in Exhaled Breath Condensate as Diagnostic Method for Non-Small Cell Lung Cancer.
Chen J; Chen J; Lv X; Yang Q; Yao S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819872271. PubMed ID: 31495334
[TBL] [Abstract][Full Text] [Related]
11. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
12. Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases.
Maniscalco M; Fuschillo S; Paris D; Cutignano A; Sanduzzi A; Motta A
Adv Clin Chem; 2019; 88():121-149. PubMed ID: 30612604
[TBL] [Abstract][Full Text] [Related]
13. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.
Conrad DH; Goyette J; Thomas PS
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):78-84. PubMed ID: 18095050
[TBL] [Abstract][Full Text] [Related]
14. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath condensate to discriminate individuals with different smoking habits by GC-TOF/MS.
Peralbo-Molina A; Calderón-Santiago M; Jurado-Gámez B; Luque de Castro MD; Priego-Capote F
Sci Rep; 2017 May; 7(1):1421. PubMed ID: 28469199
[TBL] [Abstract][Full Text] [Related]
16. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.
Hayes SA; Haefliger S; Harris B; Pavlakis N; Clarke SJ; Molloy MP; Howell VM
J Breath Res; 2016 Jul; 10(3):034001. PubMed ID: 27380020
[TBL] [Abstract][Full Text] [Related]
18. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.
Han W; Wang T; Reilly AA; Keller SM; Spivack SD
Respir Res; 2009 Sep; 10(1):86. PubMed ID: 19781081
[TBL] [Abstract][Full Text] [Related]
19. Exhaled breath condensate as a potential biomarker tool for idiopathic pulmonary fibrosis-a pilot study.
Rindlisbacher B; Strebel C; Guler S; Kollár A; Geiser T; Martin Fiedler G; Benedikt Leichtle A; Bovet C; Funke-Chambour M
J Breath Res; 2017 Nov; 12(1):016003. PubMed ID: 28775244
[TBL] [Abstract][Full Text] [Related]
20. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.
Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL
Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
